1. Home
  2. SGHT vs BGR Comparison

SGHT vs BGR Comparison

Compare SGHT & BGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • BGR
  • Stock Information
  • Founded
  • SGHT 2011
  • BGR 2004
  • Country
  • SGHT United States
  • BGR United States
  • Employees
  • SGHT N/A
  • BGR N/A
  • Industry
  • SGHT Medical Specialities
  • BGR Trusts Except Educational Religious and Charitable
  • Sector
  • SGHT Health Care
  • BGR Finance
  • Exchange
  • SGHT Nasdaq
  • BGR Nasdaq
  • Market Cap
  • SGHT 304.4M
  • BGR 351.2M
  • IPO Year
  • SGHT 2021
  • BGR N/A
  • Fundamental
  • Price
  • SGHT $5.62
  • BGR $13.09
  • Analyst Decision
  • SGHT Buy
  • BGR
  • Analyst Count
  • SGHT 6
  • BGR 0
  • Target Price
  • SGHT $7.20
  • BGR N/A
  • AVG Volume (30 Days)
  • SGHT 144.8K
  • BGR 73.3K
  • Earning Date
  • SGHT 11-07-2024
  • BGR 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • BGR 6.02%
  • EPS Growth
  • SGHT N/A
  • BGR N/A
  • EPS
  • SGHT N/A
  • BGR 0.69
  • Revenue
  • SGHT $79,395,000.00
  • BGR N/A
  • Revenue This Year
  • SGHT $3.39
  • BGR N/A
  • Revenue Next Year
  • SGHT $11.43
  • BGR N/A
  • P/E Ratio
  • SGHT N/A
  • BGR $18.97
  • Revenue Growth
  • SGHT N/A
  • BGR N/A
  • 52 Week Low
  • SGHT $1.04
  • BGR $11.38
  • 52 Week High
  • SGHT $8.45
  • BGR $13.37
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 42.60
  • BGR 54.52
  • Support Level
  • SGHT $5.74
  • BGR $12.79
  • Resistance Level
  • SGHT $6.08
  • BGR $13.28
  • Average True Range (ATR)
  • SGHT 0.31
  • BGR 0.14
  • MACD
  • SGHT -0.00
  • BGR -0.02
  • Stochastic Oscillator
  • SGHT 32.58
  • BGR 47.62

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About BGR BlackRock Energy and Resources Trust

BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.

Share on Social Networks: